-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: biotech industry
BioSpectrum Asia Survey Shows Promising Results for the Biosciences Industry
BioSpectrum Asia recently completed a survey of close to 500 bioscience companies listed on different stock exchanges in both the Asia Pacific region (APAC) and in American stock exchanges, with total revenue of $139 billion (year end 2011) and market capitalization of $200 billion. The survey says of the top 20 companies in the region, comprising mostly of pharmaceutical, biotechnology and medical technology companies and focusing on R&D, manufacturing and marketing of life sciences products, Read More >
Biotech’s Drought-Tolerant Corn Stands Tall
As drought conditions worsen across the midwest, drought-tolerant corn products are being put to the test. Because of that new technology, it isn’t causing all farmers to lose hope in the face of this summer’s drought. For the past several years, seed companies have been developing corn that can survive the dry weather. Now some of those crops are actually in the ground and farmers are waiting to see just how well they grow. “I Read More >
Just What the Doctor Ordered: Biotech’s Improved Apple
There’s a lot of buzz right now over the new “Arctic Apple,” genetically engineered to resist browning due to cutting, biting and bruising. The Golden Delicious and Granny Smith apples developed by Okanagan Specialty Fruits Inc. (OSF) are exactly like a conventional apple in every way, except for its improved trait, that will – hopefully – increase apple consumption and popularity. The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (USDA APHIS) recently Read More >
Business Confidence with the RFS Under Attack
This week, Biofuels Digest and BIO launched the quarterly Bioenergy Business Outlook Survey. Results from the first quarter of 2012 showed that industry optimism remained high earlier in the year, even though companies still reported difficulty in raising the capital needed for ongoing research and development and construction of demonstration and commercial biorefineries. Now that the petroleum refiners have launched a multi-million dollar pr campaign against the biofuel industry, it will be interesting to take Read More >
Biofuels & Climate Change
Leave a comment
Email This Post
Tags: 2011 Bioenergy Business Outlook Survey, 2012 BIO International Convention, Bioenergy Business Outlook Survey, biofuel, Biofuel Technology, biofuels, Biofuels Digest, biotech industry, Biotechnology Industry, Industry Analysis, renewable fuel standard
Tags: 2011 Bioenergy Business Outlook Survey, 2012 BIO International Convention, Bioenergy Business Outlook Survey, biofuel, Biofuel Technology, biofuels, Biofuels Digest, biotech industry, Biotechnology Industry, Industry Analysis, renewable fuel standard
BIO 2012 Super Session Recap: Burrill State-of-the-Industry Report
“How are we doing? It’s tough.” That’s what G. Steven Burrill, CEO of Burrill & Company, said at the outset of his talk to a fully packed room at the 2012 BIO International Convention Super Session featuring an overview of the 26th annual Burrill State-of-the-Industry Report. The report’s main finding was that the biotech industry is changing at a rapid pace, and is confronting a significant and newfound adversity in austerity that is caused by Read More >
